"Clinical Research Facility open to all who are interested in research studies. Drug and Device studies are being enrolled from many sponsors. Opportunities in the therapeutic areas of Dermatology, Immunology, Internal Medicine, Ear Nose and Throat, Cancer and so much more."

During the past decade, Principle Research Solutions conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Principle Research Solutions" #1 collaborator was "PPD" with 1 trials as a collaborator and "Pulmonem Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Principle Research Solutions" are "Atopic Dermatitis" (1 trials), "COVID-19" (1 trials), "Dermatitis, Atopic" (1 trials), "JAK Inhibitor" (1 trials) and "Respiratory Syncytial Virus" (1 trials). Many other conditions were trialed in "Principle Research Solutions" in a lesser frequency.

Most popular intervention types in "Principle Research Solutions" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Crisaborole 2%" (1 trials) and "Dapsone 85 mg PO BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Principle Research Solutions" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Principle Research Solutions". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Principle Research Solutions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Principle Research Solutions, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".